Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Poxvirus Infection”

204 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 204 results

Large-scale testing (Phase 3)Ended earlyNCT05937672
What this trial is testing

Cold Atmospheric Plasma Device Extension Study

Who this might be right for
Verruca VulgarisMolluscum Contagiosum
Medical University of South Carolina 60
Early research (Phase 1)Study completedNCT00053742
What this trial is testing

Phase I/II Trial of Modified Vaccinia Virus Ankara (MVA) Vaccine Against Smallpox

Who this might be right for
Healthy
National Institute of Allergy and Infectious Diseases (NIAID) 80
Post-approval studies (Phase 4)Study completedNCT04392739
What this trial is testing

Safety, Tolerability and PK of TPOXX in Adults Weighing More Than 120 KG

Who this might be right for
Smallpox
SIGA Technologies 34
Not applicableLooking for participantsNCT07085611
What this trial is testing

Neutralizing Power of Serum Antibodies - 2

Who this might be right for
COVID-19SARS-CoV-2 ViraemiaMonkey Pox+3 more
Centre Hospitalier Régional d'Orléans 30
Not applicableStudy completedNCT00928577
What this trial is testing

Safety Surveillance Cohort Study of Vaccinia Vaccine (ACAM2000®)

Who this might be right for
Smallpox
Emergent BioSolutions 14,108
Testing effectiveness (Phase 2)Study completedNCT05995275
What this trial is testing

Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ≥18 Years of Age to <50 Years of Age

Who this might be right for
SmallpoxMpox
ModernaTX, Inc. 351
Testing effectiveness (Phase 2)Ended earlyNCT02024581
What this trial is testing

A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of Molluscum Contagiosum

Who this might be right for
Molluscum Contagiosum
ViroXis Corporation 27
Not applicableStudy completedNCT06579885
What this trial is testing

Ocular Complications of Mpox in the Democratic Republic Congo

Who this might be right for
MonkeypoxMpox (Monkeypox)
Institute of Tropical Medicine, Belgium 320
Not applicableLooking for participantsNCT06616753
What this trial is testing

Evaluation of Patients' Knowledge of Their Vaccination Status and Their Relationship to Vaccination at Melun Hospital

Who this might be right for
Vaccinia
Groupe Hospitalier Sud Ile-de-France 140
Not applicableStudy completedNCT00123396
What this trial is testing

VHA Clinicians and Bioterror Events: Interactive Web-based Learning

Who this might be right for
SmallpoxAnthrax
US Department of Veterans Affairs 15
Large-scale testing (Phase 3)Active Not RecruitingNCT05597735
What this trial is testing

Assessment of the Efficacy and Safety of Tecovirimat in Patients With Monkeypox Virus Disease

Who this might be right for
MonkeypoxMpox
ANRS, Emerging Infectious Diseases 480
Early research (Phase 1)Study completedNCT00001026
What this trial is testing

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines in Vaccinia-Naive Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 56
Testing effectiveness (Phase 2)Looking for participantsNCT07379580
What this trial is testing

Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in Africa

Who this might be right for
Mpox (Monkeypox)SmallpoxOrthopoxvirus Infection
BioNTech SE 310
Early research (Phase 1)Study completedNCT00079820
What this trial is testing

Safety, Tolerability, and Immune Response of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Adults

Who this might be right for
Smallpox
Sanofi Pasteur, a Sanofi Company 110
Not applicableStudy completedNCT05522296
What this trial is testing

Break-through Infection Following Mpox vaccinatIon

Who this might be right for
Mpox
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 3,125
Testing effectiveness (Phase 2)Study completedNCT00907803
What this trial is testing

Safety, Tolerability, Pharmacokinetics (PK) of the Anti-Orthopox Drug, ST-246

Who this might be right for
Orthopoxviral Disease
SIGA Technologies 107
Very early researchWithdrawnNCT03336372
What this trial is testing

Picato for the Treatment of Molluscum Contagiosum in Immunocompromised Patients

Who this might be right for
Molluscum Contagiosum
Center for Clinical Studies, Texas
Not applicableLooking for participantsNCT06887556
What this trial is testing

Mpox Comprehensive Assessment for Responsive Immunisation in Emergency Outbreaks

Who this might be right for
Mpox
University of Birmingham 650
Not applicableAvailableNCT02080767
What this trial is testing

Tecovirimat (ST-246) Treatment for Orthopox Virus Exposure

Who this might be right for
SmallpoxMonkeypox
U.S. Army Medical Research and Development Command
Large-scale testing (Phase 3)Active Not RecruitingNCT06844500
What this trial is testing

Phase 3 Maternal Safety & Immunogenicity Trial of MVA-BN® in DRC

Who this might be right for
NeonateMaternal TransmissionMpox+5 more
Jean-Pierre Van geertruyden 359
Next Page